Immunization, Hib3 in Latin America & the Caribbean (IDA & IBRD countries)
Latin America & the Caribbean (IDA & IBRD countries): Immunization, Hib3 was 81.6% in 2024. ◆ Volatile
Immunization, Hib3 in Latin America & the Caribbean (IDA & IBRD countries), 1990–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
The most recent figure for immunization, hib3 in Latin America & the Caribbean (IDA & IBRD countries) is 81.6%, measured in 2024.
That represents a change of down 1.3% on the previous year and down 8.3% over ten years.
Over the whole period, immunization, hib3 in Latin America & the Caribbean (IDA & IBRD countries) peaked at 92.2% in 2005 and was at its lowest, 0.0%, in 1990.
Latin America & the Caribbean (IDA & IBRD countries) ranks 23rd of 43 groups on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Immunization, Hib3 in Latin America & the Caribbean (IDA & IBRD countries), year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 1990 | 0.0% | — |
| 1991 | 0.0% | — |
| 1992 | 0.0% | — |
| 1993 | 0.0% | — |
| 1994 | 0.0% | — |
| 1995 | 0.0% | — |
| 1996 | 2.3% | — |
| 1997 | 2.6% | +15.9% |
| 1998 | 11.4% | +330.0% |
| 1999 | 16.3% | +43.1% |
| 2000 | 68.6% | +321.5% |
| 2001 | 71.5% | +4.3% |
| 2002 | 76.1% | +6.4% |
| 2003 | 81.9% | +7.6% |
| 2004 | 86.6% | +5.8% |
| 2005 | 92.2% | +6.4% |
| 2006 | 91.2% | -1.1% |
| 2007 | 90.7% | -0.5% |
| 2008 | 90.5% | -0.2% |
| 2009 | 92.0% | +1.7% |
| 2010 | 91.5% | -0.6% |
| 2011 | 90.9% | -0.6% |
| 2012 | 91.3% | +0.5% |
| 2013 | 90.0% | -1.4% |
| 2014 | 89.0% | -1.1% |
| 2015 | 89.6% | +0.6% |
| 2016 | 89.1% | -0.5% |
| 2017 | 83.1% | -6.7% |
| 2018 | 84.4% | +1.6% |
| 2019 | 79.9% | -5.4% |
| 2020 | 75.9% | -5.0% |
| 2021 | 75.0% | -1.2% |
| 2022 | 78.5% | +4.7% |
| 2023 | 82.7% | +5.4% |
| 2024 | 81.6% | -1.3% |
Biggest year-on-year movements
Years where Immunization, Hib3 in Latin America & the Caribbean (IDA & IBRD countries) changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 1998 | +330.0% | 2.6% | 11.4% |
| 2000 | +321.5% | 16.3% | 68.6% |
| 1999 | +43.1% | 11.4% | 16.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 3.3% | 0.0% | 16.3% | 10 |
| 2000s | 84.1% | 68.6% | 92.2% | 10 |
| 2010s | 87.9% | 79.9% | 91.5% | 10 |
| 2020s | 78.7% | 75.0% | 82.7% | 5 |
Countries ranked near Latin America & the Caribbean (IDA & IBRD countries)
More health data for Latin America & the Caribbean (IDA & IBRD countries)
- Population ages 35-39, female, annual growth rate 0.651 % change on previous year (2025)
- Population ages 40-44, female, per capita 0.036 units per person (2025)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, annual growth rate 1.13 % change on previous year (2025)
- Population ages 35-39, male, per capita 0.037 units per person (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate 0.8899 % change on previous year (2025)
- Population ages 35-39, female, per capita 0.0377 units per person (2025)
- Population ages 35-39, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 25-29, male, per capita 0.0401 units per person (2025)
All data for Latin America & the Caribbean (IDA & IBRD countries) →
Frequently asked questions
- What is immunization, hib3 in Latin America & the Caribbean (IDA & IBRD countries)?
- Immunization, hib3 in Latin America & the Caribbean (IDA & IBRD countries) was 81.6% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Latin America & the Caribbean (IDA & IBRD countries)?
- The highest recorded value was 92.2% in 2005.
- What is the lowest immunization, hib3 recorded in Latin America & the Caribbean (IDA & IBRD countries)?
- The lowest recorded value was 0.0% in 1990.
- How does Latin America & the Caribbean (IDA & IBRD countries) rank for immunization, hib3?
- Latin America & the Caribbean (IDA & IBRD countries) ranks 23rd out of 43 groups with data for 2024.
- Is immunization, hib3 rising or falling in Latin America & the Caribbean (IDA & IBRD countries)?
- Over the last ten years it is down 8.3%. The long-run trend across the full record is volatile.
- Where does this Latin America & the Caribbean (IDA & IBRD countries) data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 35 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.